AAMA Global Healthcare Conference "AI: The Next Digital Frontier for Health...
Event Information
Event description
Description
Innovations in the technology sector and overall global development are coming together right now, bringing unprecedented growth and improvement to the healthcare and biotechnology sectors. Chief among the advances fueling this growth is artificial intelligence, or AI.
On January 13, 2020, AAMA is hosting its Global Healthcare Conference in San Francisco, held in conjunction with the industry's biggest healthcare symposium, J.P Morgan's Healthcare Conference. The AAMA Global Healthcare Conference “AI: The Next Digital Frontier for Healthcare Innovation” is bringing together recognized industry leaders, top global researchers and medical professionals, entrepreneurs, investors, and innovators from Silicon Valley and Asia to discuss the impacts of AI on biotechnology and healthcare.
Attendees of the AAMA Global Healthcare Conference will learn about highly relevant topics:
- Data-driven technologies' impact on healthcare
- Creative strategies for technology teams
- Effects of new technology on patients' and providers' daily lives
- Key points to build to attract investors looking to expand healthtech innovations
AAMA's Global Healthcare Conference will focus on healthcare and provide attendees the opportunity to learn more about AI's impact through keynote talks, panel discussions, showcases, and exhibitors. Expect to build network connections during lunch, coffee chats, and the closing reception.
Seating is limited at this exclusive conference, so register to reserve your spot today! The movers and shakers of the industry will be present on January 13, 2020 to discuss investment in healthcare and data-driven technology trends that are revolutionizing the industry. You do not want to miss out!
CONFIRMED SPEAKERS:
Atul Butte, MD, PhD
Priscilla Chan and Mark Zuckerberg
Distinguished Professor
Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
University of California, San Francisco
Chief Data Scientist
Distinguished Professor
Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
University of California, San Francisco
Chief Data Scientist
University of California Health (UC Health)
Lloyd B. Minor, MD
Carl and Elizabeth Naumann Professor for the Dean of the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery, and by courtesy, of Neurobiology and Bioengineering
Stanford University School of Medicine
Stanford University School of Medicine
Carmen Chang
General Partner; Chairman and Head, Asia, Menlo Park & China
NEA
NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With over $20 billion in assets under management, NEA was the world's largest venture capital firm in 2007.
BIO
NEA focuses investment stages ranging from seed stage through growth stage across an array of industry sectors. With over $20 billion in assets under management, NEA was the world's largest venture capital firm in 2007.
BIO
Robert S. Warren, MD
Professor of Surgery
UCSF
Co-Founder
MORE Health
MORE Health delivers access to the best physicians in the world through its cloud-based medical collaboration platform.
BIO
MORE Health delivers access to the best physicians in the world through its cloud-based medical collaboration platform.
BIO
Jerry Iwata
Director, Life Sciences Group
Professor W. John Kao
Head, BioMedical Cluster
Hong Kong Science and Technology Parks Corporation
HKSTP is a public corporation set up by the Hong Kong Government in 2001 to foster the development of innovation and technology in Hong Kong.
BIO
BIO
Aashima GuptaDirector, Global Healthcare Solutions
Andrew A. Radin
CEO and Co-Founder
twoXAR, Inc.
twoXAR is a biopharmaceutical company that uses AI to identify and develop new medicines.
BIO
twoXAR is a biopharmaceutical company that uses AI to identify and develop new medicines.
BIO
Aswin Gunasekar, MS, MBA
CEO & Founder
Zeto
Zeto provides convenient device platforms for better diagnosis and management of life-changing conditions.
Adam HaninaCEO
AiCure
A venture and NIH-funded advanced data analytics company targeting the life science and healthcare industry
Iris S. Chan
Founder and CEO
Ameriway Inc.
Ameriway focuses on early-stage investments and cross-border trades between North America and Asia.
BIO
Ameriway focuses on early-stage investments and cross-border trades between North America and Asia.
BIO
Junbao Shan
CEO and Member of Board of Directors
CICC Zhide Capital
CICC Zhide Capital is a wholly-owned private equity subsidiary of CICC
CICC Zhide Capital is a wholly-owned private equity subsidiary of CICC
John Sun
Partner
James ZhangChief Strategy Officer
Centrillion Technologies
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
BIO
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
BIO
Lei Xing
Jack Haimson Professor of Medical Physics and
Director of Medical Physics Division of Radiation Oncology Department
Jack Haimson Professor of Medical Physics and
Director of Medical Physics Division of Radiation Oncology Department
Stanford University
BIO
Edwin McCarthy
Vice President, Center for International Medicine
City of Hope National Medical Center
BIO
BIO
Mark A. Davis, MD, MS, CPE
Brigham and Women's Department of Emergency Medicine
Associate Professor Harvard Medical School
Vice President, Brigham Health International
BIO
Carrie Hurwitz Williams
Principal
McKesson Ventures
McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape.
BIO
McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape.
BIO
Dennis KimDirector, Healthcare | Emerging Healthcare Technologies
Heidi HagenChief Strategy Officer and Co-Founder
Vineti
Board of Directors
Vericel, Ziopharm, and Lykan Biosciences
Vericel, Ziopharm, and Lykan Biosciences
Pierre R. Theodore, MDVice President, Global External Innovation
Bevan Emma Huang, PhD Director, Data Sciences External Innovation
Christine ArakelianFounder and CEO
Alexis GrolinManaging Director
Michael Chan
Head of International Issuer Business
Hong Kong Exchanges and Clearing Limited (HKEx)
HKEX is a stock exchange based in Hong Kong. It is Asia's third-largest in terms of market capitalization behind the Tokyo Stock Exchange and Shanghai Stock Exchange, and the fourth single largest stock market in the world.
BIO
HKEX is a stock exchange based in Hong Kong. It is Asia's third-largest in terms of market capitalization behind the Tokyo Stock Exchange and Shanghai Stock Exchange, and the fourth single largest stock market in the world.
BIO
Mary Jo Potter
CEO and Managing Director
Xiaodong Jiang
Managing Partner
Long Hill Capital
Long Hill Capital is a leading venture capital firm investing in high-growth technology and healthcare companies in China.
BIO
Long Hill Capital is a leading venture capital firm investing in high-growth technology and healthcare companies in China.
BIO
Randy Williams
Founder and CEO
Keiretsu Forum
Keiretsu Forum is a global angel investor network with more than 2500 accredited investor members throughout 47 chapters on 3 continents.
BIO
Keiretsu Forum is a global angel investor network with more than 2500 accredited investor members throughout 47 chapters on 3 continents.
BIO
George Ugras
Managing Partner
AV8 Ventures
AV8 Ventures is a $180mil early-stage Palo Alto and London based venture capital firm aiming to partner with visionary entrepreneurs who are changing the future in data-driven health, mobility and intelligent enterprise.
BIO
AV8 Ventures is a $180mil early-stage Palo Alto and London based venture capital firm aiming to partner with visionary entrepreneurs who are changing the future in data-driven health, mobility and intelligent enterprise.
BIO
Brian A. Smith
Founder/CEO
RedCrow - Equity Crowdfunding
RedCrow connects financial and human capital to healthcare start-ups.
BIO
RedCrow connects financial and human capital to healthcare start-ups.
BIO
Ivanhoe ChangDirector
John Huber
National Sales Executive, Technology Banking Group
Lisa M. Lum
Executive Director
AAMA Silicon Valley
PRESENTERMaryanne Morrow
CEO
PRESENTERIris Wedeking
Co-Founder and CEO
PRESENTERCameron Caitlin
Chair of the Board and CEO
PRESENTERSameer Jafri
President/COO
PRESENTER
Vineet Jain
CEO
***STAY TUNED FOR SPEAKER UPDATES!***
AGENDA AT A GLANCE
9:00am-9:30am: Registration
9:30am-10:00am: Opening Keynote, plus Q&A
- Atul Butte, MD, PhD
- Priscilla Chan and Mark Zuckerberg Distinguished Professor
- Director, Bakar Computational Health Sciences Institute (bakarinstitute.ucsf.edu)
- University of California, San Francisco
- Chief Data Scientist, University of California Health (UC Health)
10:00am-10:50am: Panel Discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis and Patient Care
- Moderator: Jerry Iwata, Director – Life Sciences Group, Wells Fargo
- Aashima Gupta, Director, Global Healthcare Solutions, Google Cloud
- Aswin Gunasekar, CEO, Zeto
- Adam Hanina, CEO, AiCure
- Professor W. John Kao, Head, BioMedical Cluster, Hong Kong Science and Technology Parks Corporation
- Andrew Radin, CEO and Co-founder, twoXAR
10:50am-11:15am: AI Product Launch by MORE Health
11:15am-12:00pm: Keynote Fireside Chat
- Moderator: John Sun, Partner, Light Bridge Ventures
- Iris S. Chan, Founder and CEO, Ameriway Inc.
- Junbao Shan, CEO and Member of Board of Directors, CICC Zhide Capital, a wholly-owned private equity subsidiary of CICC
- James Zhang, Chief Strategy Officer, Centrillion Technologies
12:00pm-12:45pm: Lunch
12:45pm-1:05pm: Keynote Presentation
- Lloyd B. Minor, MD., Carl and Elizabeth Naumann Professor for the Dean of the School of Medicine, Stanford University
1:05pm-1:50pm: Panel Discussion: Provider Perspectives on the Future of Healthcare
- Moderator: Monique Dubisky, Managing Director, Healthcare Corporate Banking, Wells Fargo
- Robert S. Warren, MD, Co-founder, MORE Health
- Edwin McCarthy, Vice President, Center for International Medicine, City of Hope National Medical Center
- Mark A. Davis, MD, MS, CPE, Brigham and Women's Department of Emergency Medicine; Associate Professor Harvard Medical School; Vice President, Brigham Health International
- Lei Xing, Jack Haimson Professor of Medical Physics and Director of Medical Physics Division of Radiation Oncology Department, Stanford University
1:50pm-2:10pm: Keynote Presentation
- Chris Knackstedt, Founder, ValueIQ, LLC.; Founder, Tellus Wellness
2:10pm-2:55pm: Panel Discussion: Emerging Trends and Innovations in Biopharma
- Moderator: Dennis Kim, Director, Healthcare | Emerging Healthcare Technologies, Wells Fargo Corporate and Investment Banking
- Heidi Hagen, Chief Strategy Officer and Co-Founder, Vineti; Board of Directors - Vericel, Ziopharm, and Lykan Biosciences
- Pierre R. Theodore, MD, Vice President Global External Innovation, Johnson & Johnson Innovation
- Bevan Emma Huang, PhD, Director, Data Sciences External Innovation, Johnson & Johnson Innovation Center
- Christine Arakelian, Founder and CEO, Global Healthcare Integrators (GHI)
- Alexis Grolin, Managing Director, Creadev Investment
2:55pm-3:05pm: Coffee Break
3:05pm-3:25pm: Keynote Fireside Chat
- Moderator: Dennis Kim, Director, Healthcare | Emerging Healthcare Technologies, Wells Fargo Corporate and Investment Banking
- Carrie Hurwitz Williams, Principal, McKesson Ventures
3:25pm-3:45pm: Keynote Presentation
- Michael Chan, Head of International Issuer Business, Hong Kong Exchanges and Clearing Limited, HKEx
3:45pm-4:30pm: Panel Discussion: Venture Capital Investing in Silicon Valley and Asia: Healthcare Predictions for 2020 and Beyond
- Moderator: Mary Jo Potter, Healthcare Angels
- Carmen Chang, General Partner, Head, Asia, Menlo Park & China, NEA
- Xiaodong Jiang, Managing Partner, Long Hill Capital
- Brian A. Smith, Founder/CEO, RedCrow
- George Ugras, Managing Director, AV8 Ventures
- Randy Williams, CEO, Keiretsu Forum
4:30pm-5:25pm: Company Presentations by Top Innovators in Life Sciences and Healthcare Sectors
- 9th Gear - Same-Day FX & On-Demand Payment Liquidity.
- Avive - Developer of next generation Automated External Defibrillator (AED).
- iDentical - Developer of personalized dentail implants.
- Otonexus - Commercializing a ground-breaking ultrasound medical device to rapidly and accurately diagnose middle ear infections.
- Raydiant Oximetry - Keeping Mothers and Babies Safe During Childbirth
- OsteoPhilicty
5:25pm-5:30pm: Remarks by Ivanhoe Chang, Director, Hong Kong Economic and Trade Office, San Francisco
5:30pm-7:00pm: Networking Reception sponsored by HKETO
7:00pm: Event Concludes
*Stay tuned for program updates!
THANK YOU TO OUR SPONSORS:
PLATINUM + VENUE SPONSOR:
PLATINUM SPONSOR:
GOLD + NETWORKING RECEPTION SPONSOR:
Details on 2020’s exhibitors are forthcoming—stay tuned! If you are interested in joining us to showcase your company in 2020, contact us soon, before the remaining slots are filled.
For sponsorship, speaker, exhibitor opportunities, please contact hello@aamasv.com
***
General Information:
Wells Fargo
333 Market Street (Valet Parking Entrance - 33 Fremont Street, San Francisco, CA 94103)
Valet Parking available Mon-Fri from 6am-7pm
